Asenapine efficacy, safety, and tolerability in the treatment of acute schizophrenia: A randomized, placebo- and risperidone-controlled trial

被引：0
|
作者：
Potkin, SG
Cohen, M
Panagides, J
Jina, AS
机构：
[1] Univ Calif Irvine, Brain Imaging Ctr, Irvine, CA USA
[2] Organon USA Inc, GCD, Global Clin, Roseland, NJ USA
[3] Organon Int Inc, Clin Dev, Roseland, NJ USA
[4] Pfizer Inc, Psychiat, New York, NY USA
来源：
BIOLOGICAL PSYCHIATRY | 2006年 / 59卷 / 08期
关键词：
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
501
引用
收藏
页码：154S / 154S
页数：1
相关论文
共 50 条
  • [1] Asenapine safety and tolerability in acute schizophrenia: A placebo- and risperidone-controlled trial
    Potkin, S. G.
    Cohen, M.
    Panagides, J.
    Jina, A. S.
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2006, 9 : S276 - S276
  • [2] Asenapine safety and tolerability in acute schizophrenia: a placebo- and risperidone-controlled trial
    Potkin, S. G.
    Cohen, M.
    Panagides, J.
    Jina, A.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2006, 16 : S401 - S402
  • [3] Efficacy and tolerability of asenapine in acute schizophrenia: A placebo- and risperidone-controlled trial
    Potkin, Steven G.
    Cohen, Miriam
    Panagides, John
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 2007, 68 (10) : 1492 - 1500
  • [4] Asenapine efficacy in acute schizophrenia: A randomized, placebo- and risperidone-controlled trial
    Potkin, S. G.
    Cohen, M.
    Panagides, J.
    Jina, A. S.
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2006, 9 : S275 - S275
  • [5] Asenapine cognitive function effects in acute schizophrenia: A placebo- and risperidone-controlled trial
    Potkin, Steven G.
    Fleming, Kirsten
    Binneman, Brendon
    Keller, David S.
    Alphs, Larry
    Panagides, John
    [J]. NEUROPSYCHOPHARMACOLOGY, 2006, 31 : S251 - S251
  • [6] Asenapine, a novel psychotherapeutic agent with efficacy in positive and negative symptoms during acute episodes of schizophrenia: A randomized, placebo- and risperidone-controlled trial
    Potkin, SG
    Cohen, M
    Baker, RA
    Jina, AS
    Nettler, S
    Alphs, L
    Panagides, J
    [J]. NEUROPSYCHOPHARMACOLOGY, 2005, 30 : S112 - S113
  • [7] Asenapine cognitive function effects in acute schizophrenia: A placebo-and risperidone-controlled trial
    Potkin, S.
    Fleming, K.
    Binneman, B.
    Keller, S.
    [J]. SCHIZOPHRENIA BULLETIN, 2007, 33 (02) : 454 - 454
  • [8] Asenapine has cognitive function effects in acute schizophrenia: A placebo-controlled and risperidone-controlled trial
    Fleming, Kirsten
    Potkin, Steven G.
    Binneman, Brendon
    Keller, David S.
    Alphs, Larry
    Panagides, John
    [J]. BIOLOGICAL PSYCHIATRY, 2007, 61 (08) : 241S - 241S
  • [9] Efficacy and Safety of Asenapine in a Placebo- and Haloperidol-Controlled Trial in Patients With Acute Exacerbation of Schizophrenia
    Kane, John M.
    Cohen, Michael
    Zhao, Jun
    Alphs, Larry
    Panagides, John
    [J]. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2010, 30 (02) : 106 - 115
  • [10] Asenapine, a novel psychopharmacologic agent with efficacy in positive and negative symptoms during acute episodes of schizophrenia: A randomized, placebo-and risperidone-controlled trial
    Potkin, SG
    Cohen, M
    Baker, RA
    Jina, AS
    Alphs, L
    Nettler, S
    Panagides, J
    [J]. SCHIZOPHRENIA RESEARCH, 2006, 81 : 62 - 62
12345